Vertex Pharmaceuticals Inc / Ma

VANGUARD GROUP INC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

24,105,823

Value ($000)

10,928,616

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	10,928,616	0.2%	24,105,823	12/31/2025
2025 Q3	11/7/2025	9,484,293	0.1%	24,216,865	9/30/2025
2025 Q2	8/11/2025	10,673,126	0.2%	23,973,777	6/30/2025
2025 Q1	5/9/2025	11,388,985	0.2%	23,491,161	3/31/2025
2024 Q4	2/11/2025	9,366,113	0.2%	23,258,288	12/31/2024
2024 Q3	11/13/2024	10,771,083	0.2%	23,159,634	9/30/2024
2024 Q2	8/13/2024	10,769,086	0.2%	22,975,521	6/30/2024
2024 Q1	5/10/2024	9,479,011	0.2%	22,676,518	3/31/2024
2023 Q4	3/11/2024	9,066,396	0.2%	22,282,180	12/31/2023
2023 Q3	12/18/2023	7,644,492	0.2%	21,983,356	9/30/2023
2023 Q2	8/14/2023	7,705,407	0.2%	21,895,959	6/30/2023
2023 Q1	7/14/2023	6,883,067	0.2%	21,846,152	3/31/2023
2022 Q4	2/10/2023	6,222,315	0.2%	21,546,903	12/31/2022
2022 Q3	11/14/2022	6,118,657	0.2%	21,132,336	9/30/2022
2022 Q2	8/12/2022	5,872,075	0.2%	20,838,475	6/30/2022
2022 Q1	5/13/2022	5,342,963	0.1%	20,473,471	3/31/2022
2021 Q4	2/14/2022	4,426,224	0.1%	20,155,842	12/31/2021
2021 Q3	11/12/2021	3,708,101	0.1%	20,442,691	9/30/2021
2021 Q2	8/13/2021	4,082,849	0.1%	20,249,218	6/30/2021
2021 Q1	5/14/2021	4,387,134	0.1%	20,415,711	3/31/2021
2020 Q4	2/12/2021	4,829,146	0.1%	20,433,050	12/31/2020
2020 Q3	11/16/2020	5,630,141	0.2%	20,689,919	9/30/2020
2020 Q2	8/14/2020	6,059,687	0.2%	20,873,157	6/30/2020
2020 Q1	5/15/2020	4,903,897	0.2%	20,608,939	3/31/2020
2019 Q4	2/14/2020	4,399,633	0.2%	20,094,234	12/31/2019
2014 Q2	8/11/2014	1,581,415	0.1%	16,702,746	6/30/2014
2014 Q1	5/13/2014	1,159,006	0.1%	16,388,650	3/31/2014
2013 Q4	2/12/2014	1,168,880	0.1%	15,731,911	12/31/2013